Genomed Spólka Akcyjna (WSE: GEN)
Poland
· Delayed Price · Currency is PLN
28.80
-0.20 (-0.69%)
At close: Jan 17, 2025
Genomed Spólka Akcyjna Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 23.06 | 22.48 | 20.46 | 19.89 | 18.75 | 19.67 | Upgrade
|
Revenue Growth (YoY) | 8.03% | 9.88% | 2.84% | 6.08% | -4.67% | 5.84% | Upgrade
|
Cost of Revenue | 8.54 | 8.37 | 8.28 | 7.34 | 6.89 | 6.12 | Upgrade
|
Gross Profit | 14.53 | 14.11 | 12.18 | 12.55 | 11.87 | 13.55 | Upgrade
|
Selling, General & Admin | 11.95 | 11.48 | 10.42 | 10.11 | 10.17 | 11.01 | Upgrade
|
Other Operating Expenses | 0.72 | 0.76 | 0.67 | 0.34 | 0.52 | 0.61 | Upgrade
|
Operating Expenses | 13.34 | 12.86 | 11.82 | 11.21 | 11.4 | 12.48 | Upgrade
|
Operating Income | 1.18 | 1.24 | 0.36 | 1.34 | 0.47 | 1.08 | Upgrade
|
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0.01 | Upgrade
|
Interest & Investment Income | 0 | 0 | 0 | - | - | 0.03 | Upgrade
|
Other Non Operating Income (Expenses) | -0.18 | -0.19 | 0.01 | -0 | -0.06 | -0.04 | Upgrade
|
EBT Excluding Unusual Items | 1 | 1.05 | 0.37 | 1.33 | 0.41 | 1.06 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.02 | Upgrade
|
Pretax Income | 1 | 1.05 | 0.37 | 1.33 | 0.41 | 1.08 | Upgrade
|
Income Tax Expense | 0.13 | 0.13 | 0.03 | 0.09 | -0 | 0.08 | Upgrade
|
Net Income | 0.88 | 0.93 | 0.34 | 1.24 | 0.41 | 1 | Upgrade
|
Net Income to Common | 0.88 | 0.93 | 0.34 | 1.24 | 0.41 | 1 | Upgrade
|
Net Income Growth | 585.08% | 174.07% | -72.70% | 200.29% | -58.85% | -32.28% | Upgrade
|
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
EPS (Basic) | 0.66 | 0.70 | 0.26 | 0.94 | 0.31 | 0.76 | Upgrade
|
EPS (Diluted) | 0.66 | 0.70 | 0.26 | 0.94 | 0.31 | 0.76 | Upgrade
|
EPS Growth | 585.08% | 174.07% | -72.70% | 200.29% | -58.85% | -32.28% | Upgrade
|
Free Cash Flow | 0.08 | 1.76 | -0.6 | 1.7 | 0.88 | 0.18 | Upgrade
|
Free Cash Flow Per Share | 0.06 | 1.33 | -0.46 | 1.28 | 0.67 | 0.13 | Upgrade
|
Gross Margin | 62.98% | 62.75% | 59.52% | 63.09% | 63.27% | 68.90% | Upgrade
|
Operating Margin | 5.12% | 5.53% | 1.74% | 6.72% | 2.49% | 5.47% | Upgrade
|
Profit Margin | 3.80% | 4.12% | 1.65% | 6.22% | 2.20% | 5.09% | Upgrade
|
Free Cash Flow Margin | 0.36% | 7.84% | -2.94% | 8.52% | 4.71% | 0.89% | Upgrade
|
EBITDA | 1.85 | 1.85 | 1.08 | 2.1 | 1.17 | 1.94 | Upgrade
|
EBITDA Margin | 8.03% | 8.24% | 5.27% | 10.58% | 6.26% | 9.85% | Upgrade
|
D&A For EBITDA | 0.67 | 0.61 | 0.72 | 0.77 | 0.71 | 0.86 | Upgrade
|
EBIT | 1.18 | 1.24 | 0.36 | 1.34 | 0.47 | 1.08 | Upgrade
|
EBIT Margin | 5.12% | 5.53% | 1.74% | 6.72% | 2.49% | 5.47% | Upgrade
|
Effective Tax Rate | 12.52% | 11.94% | 8.39% | 7.11% | - | 7.53% | Upgrade
|
Revenue as Reported | 23.06 | 22.48 | 20.46 | 19.89 | 18.75 | 19.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.